{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:12:41Z","timestamp":1760933561954,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pmr.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T09:08:28Z","timestamp":1583831308000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacologic Approach to Insomnia"],"prefix":"10.1016","volume":"31","author":[{"given":"Lina","family":"Fine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pmr.2020.01.003_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/sleep\/30.4.494","article-title":"The effects of sleep deprivation on pain inhibition and spontaneous pain in women","volume":"30","author":"Smith","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.pmr.2020.01.003_bib2","unstructured":"National Sleep Foundation. The 2015 Sleep in America poll. Available at: http:\/\/www.sleepfoundation.org."},{"issue":"5","key":"10.1016\/j.pmr.2020.01.003_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib4","first-page":"237","article-title":"Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine","volume":"23","author":"Chesson","year":"2000","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: A clinical practice guideline from the American college of physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5665\/sleep.3410","article-title":"National use of prescription medications for insomnia: NHANES 1999-2010","volume":"37","author":"Bertisch","year":"2014","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.pmr.2020.01.003_bib7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","article-title":"Insomnia pharmacotherapy","volume":"9","author":"Roehrs","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw044","article-title":"Effectiveness of benzodiazepine receptor agonists in the treatment of insomnia: an examination of response and remission rates","volume":"40","author":"Pillai","year":"2017","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.pmr.2020.01.003_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.chi.0000129219.66563.aa","article-title":"Zaleplon overdose associated with sleepwalking and complex behavior","volume":"43","author":"Liskow","year":"2004","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00048679209072046","article-title":"Triazolam-induced nocturnal bingeing with amnesia","volume":"26","author":"Menkes","year":"1992","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.pmr.2020.01.003_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1389-9457(02)00007-2","article-title":"Amnestic sleep-related eating disorder associated with zolpidem","volume":"3","author":"Morgenthaler","year":"2002","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.pmr.2020.01.003_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.chi.0000150618.67559.48","article-title":"Medication-associated somnambulism","volume":"44","author":"Lange","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"Pt B","key":"10.1016\/j.pmr.2020.01.003_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2017.07.014","article-title":"Sleep, chronic pain, and opioid risk for apnea","volume":"87","author":"Marshansky","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pmr.2020.01.003_bib14","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: Case-control study","volume":"349","author":"De Gage","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.pmr.2020.01.003_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.sleep.2004.03.007","article-title":"\u201cHypnotic\u201d prescription patterns in a large managed-care population","volume":"5","author":"Roehrs","year":"2004","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.pmr.2020.01.003_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X","article-title":"Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia","volume":"13","author":"Walsh","year":"1998","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"11","key":"10.1016\/j.pmr.2020.01.003_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3949\/ccjm.83a.15129","article-title":"Serotonin syndrome: preventing, recognizing, and treating it","volume":"83","author":"Wang","year":"2016","journal-title":"Cleve Clin J Med"},{"issue":"10","key":"10.1016\/j.pmr.2020.01.003_bib18","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6\u00a0mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.pmr.2020.01.003_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004714-199210000-00006","article-title":"Fluoxetine: activating and sedating effects at multiple fixed doses","volume":"12","author":"Beasley","year":"1992","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.pmr.2020.01.003_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.JGP.0000218327.21111.de","article-title":"Paroxetine treatment of primary insomnia in older adults","volume":"14","author":"Reynolds","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.pmr.2020.01.003_bib21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.pmr.2020.01.003_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2005-864120","article-title":"Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice","volume":"38","author":"Grasm\u00e4der","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.pmr.2020.01.003_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5665\/sleep\/32.3.351","article-title":"Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia","volume":"32","author":"Mayer","year":"2009","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.pmr.2020.01.003_bib24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1185\/030079907X178874","article-title":"A\u00a02-night, 3-period, crossover study of ramelteon\u2019s efficacy and safety in older adults with chronic insomnia","volume":"23","author":"Roth","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1","article-title":"The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding","volume":"62","author":"Sutcliffe","year":"2000","journal-title":"J\u00a0Neurosci Res"},{"issue":"23","key":"10.1016\/j.pmr.2020.01.003_bib26","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.pmr.2020.01.003_bib28","doi-asserted-by":"crossref","first-page":"e1918254","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.pmr.2020.01.003_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy260","article-title":"On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers","volume":"42","author":"Vermeeren","year":"2019","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0b013e3181cda242","article-title":"Treatment effects of gabapentin for primary insomnia","volume":"33","author":"Lo","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.pmr.2020.01.003_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5664\/jcsm.26433","article-title":"Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia","volume":"2","author":"Walsh","year":"2006","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.pmr.2020.01.003_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002587","article-title":"Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial","volume":"15","author":"Sletten","year":"2018","journal-title":"PLoS Med"},{"issue":"78","key":"10.1016\/j.pmr.2020.01.003_bib33","first-page":"1","article-title":"Use of complementary health approaches among children aged 4-17 years in the United States: National Health Interview Survey, 2007-2012","author":"Black","year":"2015","journal-title":"Natl Health Stat Report"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content","volume":"13","author":"Erland","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/JCP.0b013e31816a9e4f","article-title":"Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial","volume":"28","author":"Glass","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.pmr.2020.01.003_bib36","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/sleep\/28.11.1465","article-title":"Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial","volume":"28","author":"Morin","year":"2005","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.pmr.2020.01.003_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.pmr.2020.01.003_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0031-6997(25)06841-3","article-title":"Precursor control of neurotransmitter synthesis","volume":"32","author":"Wurtman","year":"1980","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10284150500069561","article-title":"Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia","volume":"8","author":"Hudson","year":"2005","journal-title":"Nutr Neurosci"},{"issue":"5","key":"10.1016\/j.pmr.2020.01.003_bib40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"author":"Schatzberg","key":"10.1016\/j.pmr.2020.01.003_bib41"},{"key":"10.1016\/j.pmr.2020.01.003_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/DDDT.S89485","article-title":"Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Maneeton","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.pmr.2020.01.003_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"10.1016\/j.pmr.2020.01.003_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jsmc.2014.02.007","article-title":"Cognitive-behavioral therapy for comorbid insomnia and chronic pain","volume":"9","author":"Finan","year":"2014","journal-title":"Sleep Med Clin"},{"issue":"5","key":"10.1016\/j.pmr.2020.01.003_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ptj\/pzy020","article-title":"Sleep disturbances in chronic pain: Neurobiology, assessment, and treatment in physical therapist practice","volume":"98","author":"Nijs","year":"2018","journal-title":"Phys Ther"},{"issue":"4","key":"10.1016\/j.pmr.2020.01.003_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965120300036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965120300036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:41:23Z","timestamp":1760931683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965120300036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1047965120300036"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2020.01.003","relation":{},"ISSN":["1047-9651"],"issn-type":[{"type":"print","value":"1047-9651"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Approach to Insomnia","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}